Protagenic Therapeutics, Inc.\new Payments for Repurchase of Initial Public Offering
Protagenic Therapeutics, Inc.\new (PTIX) reported Payments for Repurchase of Initial Public Offering of $157.04 thousand for the 6-month period ending 2024-09-30, per its 10-Q filed 2025-11-26.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfInitialPublicOffering · last filed 2025-11-26
- Protagenic Therapeutics, Inc.\new payments for repurchase of initial public offering for the quarter ending 2024-09-30 was -$102.91K.
- Protagenic Therapeutics, Inc.\new payments for repurchase of initial public offering for the quarter ending 2024-06-30 was $259.95K.
| Period end | Payments for Repurchase of Initial Public Offering 3 month | Payments for Repurchase of Initial Public Offering 6 month |
|---|---|---|
| 2024-09-30 | -$102.91K derived: 10-Q 6 month − 10-QT 3 month · filed 2025-11-26 | $157.04K 10-Q · filed 2025-11-26 |
| 2024-06-30 | $259.95K 10-QT · filed 2025-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |